The zebrafish homologs of SET/I2PP2A oncoprotein: expression patterns and insights into their physiological roles during development

被引:10
|
作者
Serifi, Iliana [1 ,2 ]
Tzima, Eleni [1 ,2 ]
Soupsana, Katerina [1 ,2 ]
Karetsou, Zoe [1 ]
Beis, Dimitris [3 ]
Papamarcaki, Thomais [1 ,2 ]
机构
[1] Univ Ioannina, Sch Med, Biol Chem Lab, Ioannina, Greece
[2] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Div Biomed Res, Ioannina, Greece
[3] Biomed Res Fdn Acad Athens, Dev Biol, Athens, Greece
关键词
ACUTE UNDIFFERENTIATED LEUKEMIA; LATERAL-LINE PRIMORDIUM; RETINAL GANGLION-CELL; ACTIVATING-FACTOR-I; TUMOR-SUPPRESSOR; SET PROTEIN; MYELOID LEUKEMOGENESIS; HISTONE ACETYLATION; PUTATIVE ONCOGENE; HAIR-CELLS;
D O I
10.1042/BCJ20160523
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncoprotein SET/I2PP2A (protein phosphatase 2A inhibitor 2) participates in various cellular mechanisms such as transcription, cell cycle regulation and cell migration. SET is also an inhibitor of the serine/threonine phosphatase PP2A, which is involved in the regulation of cell homeostasis. In zebrafish, there are two paralogous set genes that encode Seta (269 amino acids) and Setb (275 amino acids) proteins which share 94% identity. We show here that seta and setb are similarly expressed in the eye, the otic vesicle, the brain and the lateral line system, as indicated by in situ hybridization labeling. Whole-mount immunofluorescence analysis revealed the expression of Seta/b proteins in the eye retina, the olfactory pit and the lateral line neuromasts. Loss-of-function studies using antisense morpholino oligonucleotides targeting both seta and setb genes (MOab) resulted in increased apoptosis, reduced cell proliferation and morphological defects. The morphant phenotypes were partially rescued when MOab was co-injected with human SET mRNA. Knockdown of setb with a transcription-blocking morpholino oligonucleotide (MOb) resulted in phenotypic defects comparable with those induced by setb gRNA (guide RNA)/Cas9 [CRISPR (clustered regularly interspaced short palindromic repeats)-associated 9] injections. In vivo labeling of hair cells showed a significantly decreased number of neuromasts in MOab-, MOb-and gRNA/Cas9-injected embryos. Microarray analysis of MOab morphant transcriptome revealed differential expression in gene networks controlling transcription in the sensory organs, including the eye retina, the ear and the lateral line. Collectively, our results suggest that seta and setb are required during embryogenesis and play roles in the zebrafish sensory system development.
引用
收藏
页码:4609 / 4627
页数:19
相关论文
共 50 条
  • [1] Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
    C H Switzer
    R Y S Cheng
    T M Vitek
    D J Christensen
    D A Wink
    M P Vitek
    Oncogene, 2011, 30 : 2504 - 2513
  • [2] Characterization of SET/I2PP2A Isoforms in Dogs
    Yabe, Ryotaro
    Fujiwara, Nobuyuki
    Mizuno, Takuya
    Usui, Tatsuya
    Ohama, Takashi
    Sato, Koichi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2014, 76 (09): : 1235 - 1240
  • [3] Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
    Switzer, C. H.
    Cheng, R. Y. S.
    Vitek, T. M.
    Christensen, D. J.
    Wink, D. A.
    Vitek, M. P.
    ONCOGENE, 2011, 30 (22) : 2504 - 2513
  • [4] The role of SET/I2PP2A in canine mammary tumors
    Satoru Kake
    Shunya Tsuji
    Shuhei Enjoji
    Sayaka Hanasaki
    Hiroshi Hayase
    Ryotaro Yabe
    Yuiko Tanaka
    Takayuki Nakagawa
    Hao-Ping Liu
    Shih-Chieh Chang
    Tatsuya Usui
    Takashi Ohama
    Koichi Sato
    Scientific Reports, 7
  • [5] Distribution of SET/I2PP2A protein in gastrointestinal tissues
    Umata, Koji
    Sakai, Yusuke
    Ikeda, Shunta
    Tsuji, Shunya
    Kawasaki, Hideyoshi
    Ohama, Takashi
    Sato, Koichi
    PLOS ONE, 2019, 14 (09):
  • [6] The Role of PP2A inhibitor SET/I2PP2A in Gastric Cancer
    Enjoji, Shuhei
    Yabe, Ryotaro
    Yoshimura, Kazuhiro
    Kawasaki, Hideyoshi
    Sakurai, Masashi
    Sakai, Yusuke
    Takenouchi, Hiroko
    Yoshino, Shigefumi
    Hazama, Shoichi
    Nagano, Hiroaki
    Ohshima, Hiroko
    Ohshima, Masanobu
    Vitek, Michael P.
    Matsuura, Tetsuya
    Hippo, Yoshitaka
    Usui, Tatsuya
    Ohama, Takashi
    Sato, Koichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S155 - S155
  • [7] The role of SET/I2PP2A in canine mammary tumors
    Kake, Satoru
    Tsuji, Shunya
    Enjoji, Shuhei
    Hanasaki, Sayaka
    Hayase, Hiroshi
    Yabe, Ryotaro
    Tanaka, Yuiko
    Nakagawa, Takayuki
    Liu, Hao-Ping
    Chang, Shih-Chieh
    Usui, Tatsuya
    Ohama, Takashi
    Sato, Koichi
    SCIENTIFIC REPORTS, 2017, 7
  • [8] The role of PP2A inhibitor SET/I2PP2A in gastric cancer
    Enjoji, Shuhei
    Yoshimura, Kazuhiro
    Fujiwara, Nobuyuki
    Oshima, Hiroko
    Oshima, Masanobu
    Usui, Tatsuya
    Ohama, Takashi
    Sato, Koichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S181 - S181
  • [9] Oncogenic Role of SET/I2PP2A for Gynecologic Cancers
    Jiang, Shi-Wen
    Xu, Siliang
    Chen, Haibin
    Liu, Jiayin
    Duan, Ping
    CURRENT DRUG TARGETS, 2017, 18 (10) : 1152 - 1157
  • [10] Role of SET/I2PP2A in canine mammary tumors
    Tsuji, Shunya
    Kake, Satoru
    Enjoji, Shuhei
    Hanasaki, Sayaka
    Hayase, Hiroshi
    Yabe, Ryotaro
    Tanaka, Yuiko
    Nakagawa, Takayuki
    Usui, Tatsuya
    Ohama, Takashi
    Sato, Koichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S155 - S155